Synthesis of Secondary Metabolites in Filamentous Fungi
Patent 14014/TUB

This Invention contains the process of synthesis of secondary metabolites in fungal host organisms for the production of novel antibiotics.

Benefits
  1. High yield and purity
  2. Controllable cultivation inside bio reactors
  3. Usage of fungal expression systems
  4. Fungi or its enzymes can be modified
Possible Applications

Pharmacy, anti-biotics, biological research

Background

Fungal secondary metabolites have a long history as antibiotic agents. One prominent example is penicillin. Novel antibiotics are often based on cyclic depsipeptides (CDPs). However, the production of these antibiotics on an industrial scale is known to be problematic. Optimization of the synthesis can be achieved by using fungal expression systems.

Technical Description

The innovation presented here contains a process for the synthesis of secondary metabolites such as cyclodepsipeptides in fungal host organisms (genera: Aspergillus, Penicillum, yeast). The necessary fungal enzymes can be modified by the introduction of altered gene sequences (synthetic or designed by PCR). Expression is performed by an inducible, controllable and metabolism-independent system, such as the tetracycline (Tet) system. This system can be switched on or off by constitutive, inducible or suppressible promoters and thus offers the possibility for further optimization. Following fed-batch cultivation, the extraction of the secondary metabolite from the biomass achieves satisfactory yields with high purity and low background contamination by other metabolites.

Contact Us

Ina Krüger

License Manager

+49 (0)30 314-75916
ina.krueger@tu-berlin.de

Technology Readiness Level
TRL 4

Small scale prototype

Property Rights

pending: IL, US, CN, CA
approved: DK, FI, FR, DE, CH, GB, ES, AT, SE, JP, NL

Patent Holder

Technische Universität Berlin

Possible Cooperation
  • R&D Cooperation
  • Patent Purchase
  • Licensing